All India Institute of Medical Sciences Bhubaneswar, formerly Netaji Subhas Chandra Bose All India Institute of Medical Sciences, is a medical college and medical research public university located in Bhubaneswar, Odisha, India.

During the past decade, All India Institute of Medical Sciences conducted 25 clinical trials. In the 10-year time frame, 25 clinical trials started and 1 clinical trials were completed, i.e. on average, 4% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 1 clinical trials were completed. i.e. 7.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "All India Institute of Medical Sciences" #1 sponsor was "All India Institute of Medical Sciences, Bhubaneswar" with 21 trials, followed by "Aurigene Discovery Technologies Limited" with 1 trials sponsored, "Eisai Inc." with 1 trials sponsored, "Eli Lilly and Company" with 1 trials sponsored and "Geron Corporation" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "All India Institute of Medical Sciences" #1 collaborator was "Coconut Development Board, Government of India" with 1 trials as a collaborator and "Indian Council of Medical Research" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "All India Institute of Medical Sciences" are "Breast Neoplasms" (2 trials), "Major Depressive Disorder" (2 trials), "Acne Vulgaris" (1 trials), "Adolescent Migraine" (1 trials) and "Anal Fissure" (1 trials). Many other conditions were trialed in "All India Institute of Medical Sciences" in a lesser frequency.

Most popular intervention types in "All India Institute of Medical Sciences" are "Drug" (22 trials), "Other" (3 trials), "Dietary Supplement" (2 trials), "Device" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Oxcarbazepine" (2 trials), "AUR105" (1 trials), "Adapalene 0.1% gel plus clindamycin 1% gel" (1 trials) and "Alpha lipoic acid 300mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "All India Institute of Medical Sciences" are 22 trials for "All" genders, 2 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "All India Institute of Medical Sciences". 1 are not yet recruiting, 11 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in All India Institute of Medical Sciences, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in All India Institute of Medical Sciences, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 14 trials, and there were also 4 trials that are defined as “Not Applicable".

All India Institute of Medical Sciences has several departments that took part in Clinical trials: "Dept of Psychiatry, Aiims, Bhubaneswar" - 2 trials